scPharmaceuticals Inc. (NASDAQ:SCPH) saw a downside of -1.04% to $8.09 after subtracting -$0.08 on Monday. The 5-day average trading volume is 275,957 shares of the company’s common stock. It has gained $8.44 in the past week and touched a new high 1 time within the past 5 days. An average of 289,619 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 457,658.
SCPH’s 1-month performance is -6.85% or -$0.51 on its low of $8.01 reached on 07/24/23. The company’s shares have touched a 52-week low of $3.68 and high of $12.75, with the stock’s rally to the 52-week high happening on 05/11/23. YTD, SCPH has achieved 12.76% or $1.00 and has reached a new high 10 times. However, the current price is down -36.59% from the 52-week high price.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
SCPH stock investors last saw insider trading activity on Nov 25.5AM Partners IV, LLC (10% Owner) most recently sold 562,466 shares at $4.09 per share on Oct 10. This transaction cost the insider $2,300,486. 10% Owner, 5AM Partners IV, LLC, sold 37,534 shares at a price of $5.02 on Oct 06. Then, on Sep 07, 10% Owner 5AM Partners IV, LLC sold 200,000 shares at a price of $4.75 per share. This transaction amounted to $950,000.
Valuation Metrics
SCPH stock has a beta of 0.17. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 138.87 while the price-to-book (PB) in the most recent quarter is 4.02.
scPharmaceuticals Inc.’s quick ratio for the period ended March 30 was 15.90, with the current ratio over the same period at 16.40. In terms of profitability, the gross margin trailing 12 months is 70.70%. The firm’s gross profit as reported stood at $3.3 million against revenue of $36.16 million.
Earnings Surprise
For the quarterly period ending March 30 this year, scPharmaceuticals Inc.’s cash and short-term investments amounted to $40.62 million against total debt of $37.68 million. Net income grew 31.04% to -$11.21 million, while revenue of -$9.25 million was 17.48% off the previous quarter. Analysts expected SCPH to announce -$0.36 per share in earnings in its latest quarter, but it posted -$0.3, representing a 16.70% surprise. EBITDA for the quarter stood at more than -$11.45 million. SCPH stock balance sheet for the quarter ending March 30 shows that total liabilities totaled 51.56 million, with total debt at $37.68 million. Shareholders hold equity totaling $35.77 million.
Let’s look briefly at scPharmaceuticals Inc. (SCPH) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 04 August was 36.04% to suggest the stock is trending Neutral, with historical volatility in this time period at 20.32%.
The stock’s 5-day moving average is $8.22, reflecting a -3.08% or -$0.26 change from its current price. SCPH is currently trading -9.32% above its 20-day SMA, +16.05% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -24.84% and SMA200 by+45.12%.
Stochastic %K and %D was 25.08% and 26.68% and the average true range (ATR) pointed at 0.32. The RSI (14) points at 36.51%, while the 14-day stochastic is at 23.18% with the period’s ATR at 0.38. The stock’s 9-day MACD Oscillator is pointing at -0.05 and -0.08 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for scPharmaceuticals Inc. (NASDAQ: SCPH), Cowen launched coverage with an Outperform rating. Analysts offering their rating for SCPH stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate SCPH as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 5 have offered a “buy” rating.
What is SCPH’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $16.00 and a high of $25.00, with their median price target at $18.00. Looking at these predictions, the average price target given by analysts is for scPharmaceuticals Inc. (SCPH) stock is $19.20.
